Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 7Prostatic Neoplasms 4Precancerous Conditions 2Neoplasms 2Weight Loss 1Uterine Cervical Neoplasms 1Radiation Injuries 1Psoriasis 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Pelvic Inflammatory Disease 1Pain 1Ovarian Neoplasms 1Osteoarthritis 1Fatigue 1Esophageal Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthralgia 1

Interventions

Exercise 7Caloric Restriction 5Diet 4Cognitive Behavioral Therapy 3Octreotide 2Metformin 2Eicosapentaenoic Acid 2Diet Therapy 2Weight Reduction Programs 1TOPS 1Sugars 1Standard of Care 1Sampling Studies 1Resistance Training 1Psychology, Positive 1Population Groups 1Palliative Care 1Nutritional Status 1Nutrition Assessment 1Methods 1Melatonin 1Inositol 1Ibuprofen 1Hypoxanthine Phosphoribosyltransferase 1Growth Differentiation Factor 15 1Fatty Acids, Omega-3 1Endoscopy, Digestive System 1Docosahexaenoic Acids 1Diet, Vegetarian 1Diet, Vegan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Weight Loss × Fatty Acids, Omega-3 × Clear all
NCT02101970 2022-01-24

Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women

University of Kansas Medical Center

Phase NA Completed
46 enrolled
Breast

Breast Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡